MagLab Research Paves the Way for Better Flu Treatments

Article

New research by a Florida State University chemistry professor uses some of the world's most powerful magnets to put a bullseye on the flu virus. Led by professor of chemistry and biochemistry Tim Cross and his team at the Florida State University-based National High Magnetic Field Laboratory, scientists delved into the complexities of exactly how the flu virus works and why it's so effective at making people so sick. With a better understanding of how it works, researchers will now be able to turn their attention to creating more effective prescription drugs to fight the flu.

Cross and his team were able to detail the mechanism that activates the flu virus permitting it to reproduce in a human cell. They laid out their findings in the academic journal Structure.

"If we can get a drug that disrupts this mechanism, that would be huge," Cross says. "We really don't know when a deadly flu epidemic is going to hit next. We need backup to vaccines."

But to create those drugs, scientists needed to first understand how the virus functions on its most basic level.

The influenza virus is what's known as an enveloped virus, meaning it has a membrane coat, similar to the way a cell has a membrane. In that membrane are three different proteins, one of which is called the M2 proton channel.

As the virus moves into a cell, it enters an acidic environment, which activates the M2 proton channel. Once the M2 proton channel is activated, protons move through the channel and compel the membrane coat to fuse to the host membrane, causing infection and ultimately, reproduction of the virus.

Using the National MagLab's most sensitive nuclear magnetic resonance magnet -- essentially a super powered MRI -- scientists were able to get a clear image of the channel and how protons moved through it causing the fusion of the virus with the host membranes.

"We can actually see the protons move," Cross says. "Nobody thought we would be able to do this."

For years, scientists worldwide have been fixated on how this channel works because it provides the basic clues to understanding how viral infection works. The M2 channel has long been a target of drug developers, but when the swine flu broke out in 2009, doctors quickly discovered that drugs that had been in use for decades suddenly didn't work.

"The drugs didn't work anymore," Cross says. "As in so many cases, the virus had evolved. So, there's a lot of interest in studying this protein and seeing if we can develop a new antibiotic."

Cross' work was funded by the National Institutes of Health and the National Science Foundation.

The paper's co-authors are Professor of Physics Huan-Xiang Zhou, MagLab scientist Riqiang Fu and former FSU graduate student Yimin Miao.

Source: Florida State University

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content